Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Phase I/II results for promising compound from BioTransplant and MedImmune

May 20, 1997

BioChem Pharma subsidiary signs agreement to develop nasally delivered vaccines

May 14, 1997

Fujisawa's Prograf cleared by FDA for use in kidney transplantation

May 9, 1997

Nippon Shinyaku prepares improved ciclosporin derivatives

May 9, 1997

Aquila's QS-21 enhances immune response of DNA vaccines in preclinical studies

May 9, 1997

Alexion issued two patents covering technology for xenotransplantation products

May 9, 1997

Zeneca and University of California to codevelop drugs for immunosuppression

May 8, 1997

Novel semisynthetic macrolide immunosuppressants disclosed by Abbott

May 7, 1997

Potential HSV-2 vaccine described by Aviron

May 5, 1997

Novel immunosuppressants from Takeda

April 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...